Clinical Trials Directory

Trials / Unknown

UnknownNCT04449289

Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Study aims to compare the influence of intravenous lidocaine and peridural ropivacaine on postoperative long and short term outcome in patients with pancreatic cancer undergoing surgery. As short term endpoints: postoperative complications and resumption of bowel function. Long term endpoints include: 1 and 3 year recurrence and mortality.

Conditions

Interventions

TypeNameDescription
DRUGIntravenous lidocaineIntraoperatively and postoperatively a standard intravenous infusion of lidocaine will be used for analgesia
DRUGEpidural ropivacaineIntraoperatively and postoperatively an epidural infusion of ropivacaine will be used for analgesia

Timeline

Start date
2020-07-01
Primary completion
2021-12-31
Completion
2024-12-31
First posted
2020-06-26
Last updated
2020-06-26

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT04449289. Inclusion in this directory is not an endorsement.